Rubella

Generalities
Agent	Rubella virus, genus Rubullovirus, family Togaviridae
Incubation period	14-17 days (range 14-21 days)
Period of transmissibility	- 7 days before rash and 4 days after rash onset - From congenital rubella: infants shed the virus for several months after birth
Reservoir	Humans
Modes of transmission	- Person-to-person: direct contact with droplets - Infants with Congenital Rubella Syndrome shed large quantities of virus in their pharyngeal secretions and urine. - Materno-foetal transmission: 90% of infants born to women infected with rubella during the 1st trimester. The risk of transmission is 10-20% by the 16th week, and rare after the 20th week.
Clinical presentation	- Febril maculo-papular rash - Complications: thrombocytopenia (1/3000), post-infectious encephalitis (1/6000), rarely chronic arthritis - Congenital Rubella Syndrome: Congenital malformation as deafness, cataracts, microphtalmia, congenital glaucoma, pigmentary retinopathy, nystagmus, microcephaly, meningo-encephalitis, mental retardation, patent ductus arteious, atrial or ventricular septal defects, other congenital heart disease, purpura, hepatosplenomegaly, jaundice, radiolucent bone disease
Resources
Case definitions	- MOPH circular no 12 (2013): Acquired Rubella - MOPH circular no 45 (2007): Congenital Rubella Syndrome
Forms	- Rash reporting form - CRS reporting form - Rash investigation form - CRS investigation form
Data	- Rubella 2021 - Rubella 2020 - Rubella 2019 - Rubella 2018 - Rubella 2017 - Rubella 2016 - Rubella 2015

ATC	Name	B/G	Ingredients	Dosage	Form	Price
G01AX	ENTEROGERMINA	B	Bacillus clausii spores - 2 Billions		Capsule	831,839 L.L
G01AX	ENTEROGERMINA	B	Bacillus clausii spores - 6 Billions/2g	6 billions/2g	Powder for suspension	1,493,009 L.L
G01AX	ENTEROGERMINA	B	Bacillus clausii spores - 6 Billions/2g	6 billions/2g	Powder for suspension	1,343,843 L.L
G01AF05	ECOGYN	G	Econazole nitrate - 150mg	150mg	Pessary	447,948 L.L
G01AF05	ECONAZ	G	Econazole nitrate - 150mg	150mg	Ovule	415,951 L.L
G01AF05	ECOREX 150	G	Econazole nitrate - 150mg	150mg	Ovule	280,863 L.L
D11AH02	ELIDEL	B	Pimecrolimus - 10mg/g	1%	Cream	1,780,591 L.L
D10AF02	ERYFLUID	B	Erythromycin base - 40mg/ml	4%	Lotion	486,471 L.L
D10AF02	ERYFLUID	B	Erythromycin base - 4%	4%	Lotion	486,471 L.L
D10AF02	ERYTHROMYCIN 1.5 %	G	Erythromycin - 15mg/ml	1.5 %	Solution	501,701 L.L
D10AD53	EPIDUO	B	Adapalene - 0.1%, Benzoyl peroxide - 2.5%		Gel	2,088,331 L.L
D10AD53	EPIDUO FORTE	B	Adapalene - 0.3%, Benzoyl peroxide - 2.5%		Gel	2,201,214 L.L
D10AD51	ERYLIK	G	Tretinoin - 0.025%, Erythromycin - 4%		Gel	378,964 L.L
D08AX02	EOSIN ALCOHOLIC	G	Eosin - 2%	2%	Solution	115,187 L.L
D08AX02	EOSIN AQUEUSE	G	Eosin - 2%	2%	Solution	98,548 L.L
D08AX02	EOSIN ALCOHOLIC	G	Eosin - 1%	1%	Solution	108,787 L.L
D08AX02	EOSIN AQUEUSE	G	Eosin - 1%	1%	Solution	84,470 L.L
D08AX01	EAU OXYGENEE 10/120	G	Hydrogen peroxide - 10V	10V	Solution	119,026 L.L
D07XC03	ELICA M	G	Mometasone furoate - 0.1%, Miconazole nitrate - 2%		Cream	459,594 L.L
D07XC03	ELICASAL	G	Mometasone furoate - 1mg/g, Salicylic acid - 50mg/g		Ointment	462,282 L.L
D07XB05	ECOZONE	G	Dexamethazone sodium phosphate - 0.1%, Econazole nitrate - 1%		Cream	364,757 L.L
D07AC13	ELICA	G	Mometasone furoate - 1mg/g	0.1%	Cream	341,336 L.L
D07AC13	ELISONE	G	Mometasone furoate - 0.1%	0.1%	Cream	249,955 L.L
D07AC13	ELISONE	G	Mometasone furoate - 0.1%	0.1%	Cream	435,405 L.L
D07AC13	ELICA	G	Mometasone furoate micronized - 1mg/g	0.1%	Ointment	399,121 L.L
D07AC13	ELOCOM	B	Mometasone furoate - 1mg/g	0.1%	Lotion	282,207 L.L
D01AE22	EXODERIL	B	Naftifine HCl - 10mg/g	1%	Cream	345,368 L.L
D01AE22	EXODERIL	B	Naftifine HCl - 10ml/ml	1%	Solution	159,917 L.L
D01AC03	ECONAZ	G	Econazole nitrate - 1%	1%	Cream	307,164 L.L
C10AX09	EZETROL	B	Ezetimibe - 10mg	10mg	Tablet	3,680,849 L.L